ArticleJPRAS open2025
Skin subdermal adhesion technique for upper blepharoplasty treatment for dermatochalasis.
Article in JPRAS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: We developed a simple bipolar skin and subdermal hemostasis technique called the "Skin Subdermal Adhesion Technique" (SAT), which prevents postoperative complications and provides good cosmetic results. Patients and Methods: We performed 40 ptosis surgeries in 20 patients using SAT. All patients underwent bilateral excision of the excess skin due to age-related upper eyelid skin laxity; patients with facial nerve palsy and those who underwent manipulation of the levator muscle were excluded. The maximum wound width of the defect after skin resection and diameter after SAT were measured. Additionally, the presence or absence of postoperative complications requiring additional surgeries or procedures was investigated. Results: The mean (range) age was 76.0 (55-86) years. Among the bilateral resection widths, the diameter of the wider side was 11-20 mm (mean, 14.85±2.67 mm). In contrast, the defect width after SAT was 8-13 mm (mean, 9.75±1.84 mm). SAT reduced the maximum width by 34.3%. There were no cases of postoperative complications, such as wound hematoma formation or infection. Conclusion: SAT is useful for treating upper eyelid skin defects because it does not require any special equipment, is quick to perform, reduces the risk of postoperative complications such as hematoma, and provides good cosmetic results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.